Long-term outcomes after revascularization and medical therapy in premature coronary artery disease for

Farbod Ebadi Fard Azar1, Ali Aboutorabi2, Mohammad Afrouzi2

  • 1Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran.

Insights

This study compares long-term outcomes for premature coronary artery disease patients treated with coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or medical therapy (MT). Findings inform cost-effectiveness analyses for these vital treatments.

Area of Science:

  • Cardiology
  • Health Economics
  • Systematic Reviews

Background:

  • Premature coronary artery disease (CAD) necessitates understanding long-term outcomes for effective cost-effectiveness analysis.
  • Revascularization options include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), alongside medical therapy (MT).

Purpose of the Study:

  • To systematically review and analyze the long-term outcomes of CABG, PCI, and MT in patients with premature CAD.
  • To provide essential data for calculating event probabilities crucial for cost-effectiveness and cost-utility studies.

Main Methods:

  • Systematic review of studies from major databases (PubMed, Web of Science, Scopus, Embase).
  • Inclusion criteria: patients aged 18-60 years.
  • Random-effects meta-analysis to assess long-term outcomes, reporting risk ratios and adverse event probabilities.

Main Results:

  • The study will ascertain probabilities of adverse events over specific periods for each treatment modality.
  • Outcomes will be compared based on specific patient characteristics.

Conclusions:

  • This systematic review offers critical insights into the long-term outcomes of CABG, PCI, and MT for premature CAD.
  • The findings are valuable for both clinical decision-making and economic evaluations, including cost-effectiveness and cost-utility analyses.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
68
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
49
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
56
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
44